Latest News Feed
Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts
Management to discuss the ongoing Phase 1/2 diabetic foot ulcer trial, upcoming clinical catalysts, broader pipeline opportunities, and an intellectual property portfolio of approximately 270 issued and pending patents
Learn how 60 Degrees Pharmaceuticals is building on its FDA-approved antimalarial ARAKODA® while advancing tafenoquine for a growing tick-borne disease with no FDA-approved treatment
Management to discuss the hospitalized babesiosis study, upcoming interim data readout, potential regulatory pathway, U.S. market opportunity, and 2026 commercial expansion of ARAKODA®
Learn how VENU is developing a nationwide portfolio of multi-seasonal, multi-configuration, omni-content premium amphitheaters in underserved, high-growth markets
Founder, Chairman and CEO J.W. Roth to discuss the Company's innovative financing model, $290M+ in premium ownership sales, and development pipeline
Learn how Anixa is advancing two clinical-stage oncology programs through differentiated immunotherapy and vaccine approaches
Management to discuss CAR-T clinical progress, completed Phase 1 breast cancer vaccine trial, planned Phase 2 development, and upcoming milestones
Learn how edgeTI's defense-ready edgeCore platform unifies disparate systems, applications and data into a real-time operating environment without costly rip-and-replace projects
Management to discuss growing defense-sector momentum, 211% first-half revenue growth, expanding recurring revenue, the land-and-expand software model, and multiple growth levers across organic expansion and M&A
Learn how First Phosphate is advancing a vertically integrated strategy spanning high-purity phosphate concentrate, purified phosphoric acid, and downstream LFP battery materials
Management to discuss the Bégin-Lamarche project, updated mineral resource, PEA economics, definitive offtake agreements, and potential project-financing pathways
Learn how New Horizon Aircraft is addressing the range, payload, and infrastructure limitations facing first-generation eVTOL platforms
Management to discuss the Cavorite X7's competitive positioning, patented technology, target performance, capital-efficient business model, and key milestones toward commercialization
Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancers
Management to discuss TTX-MC138, the ongoing Phase 2a colorectal cancer trial, tumor-targeted RNA delivery, and multiple upcoming clinical catalysts
BioVie CEO Cuong Do to discuss newly reported Phase 2 data showing bezisterim's potential across key Long COVID symptoms
Learn why the ADDRESS-LC findings, together with recent Parkinson's data, could strengthen the case for targeting inflammation and insulin resistance across neurological disorders
Learn how FibroBiologics is developing an off-the-shelf therapeutic platform designed to harness the regenerative and immune-modulating properties of fibroblasts
Management to discuss the ongoing Phase 1/2 diabetic foot ulcer trial, upcoming clinical catalysts, broader pipeline opportunities, and an intellectual property portfolio of approximately 270 issued and pending patents
Learn how TransCode Therapeutics is advancing RNA therapeutics, cancer vaccines, and immuno-oncology programs designed to address advanced and metastatic cancers
Management to discuss TTX-MC138, the ongoing Phase 2a colorectal cancer trial, tumor-targeted RNA delivery, and multiple upcoming clinical catalysts
Learn how Hawkeye is leveraging deep digital asset industry relationships and capital markets expertise to build an integrated merchant banking and private equity platform through proprietary deal flow, strategic advisory, investments and acquisitions
Live investor webinar rescheduled for September 24 at 4:15 p.m. ET
Learn how Clinch is advancing fully permitted, infrastructure-backed metallurgical coal assets toward production in the Central Appalachian basin
Discover why the Company's low-cost production profile, strategic resource base, and multiple embedded growth opportunities position it for long-term value creation
CEO James Foster to discuss the Company's financial and strategic position, commercial strategy for ImmuneSelect and development plans for ViraxImmune™
Webinar to include an overview of recent corporate developments and management's priorities for the coming months and quarters
Learn how Bimergen is advancing a diversified portfolio of utility-scale and distributed battery energy storage projects toward construction and commercial operation
Management to discuss Q2 2026 results, including $7.9M in revenue and $3.9M in Adjusted EBITDA, alongside the Company's growing 2.0 GW development pipeline and capital-efficient growth strategy
Learn how Proactive Sustainable Bonds provides access to a real estate-backed fixed-income investment strategy supported by workforce and affordable housing assets
Discover why the platform's established operating history, third-party validation, and workforce and affordable housing strategy position it to benefit from favorable long-term market fundamentals
BioVie CEO Cuong Do to discuss the newly released Phase 2 SUNRISE-PD results and what they mean for the future development of bezisterim in Parkinson's disease
Learn how the BioVie's differentiated approach to targeting neuroinflammation and insulin resistance could position bezisterim as a potential first-line therapy in early-stage Parkinson's disease
Learn how Nord's dual-track strategy combines near-term silver production from tailings reprocessing with district-scale exploration across Ontario's historic Cobalt-Gowganda silver camp
Discover why Nord's world-class high-grade silver resources, existing infrastructure, and multiple near-term catalysts position the Company for long-term value creation
Learn how OwlTing is building enterprise-grade financial infrastructure that enables regulated stablecoin and fiat payments across global markets
Discover why OwlPay's rapidly expanding payments platform, strategic partnerships with Visa and Circle, and scalable business model position OwlTing for long-term growthy
As LFP batteries are now the dominant chemistry for energy storage, data centers and mobility applications, secure access to battery-grade high-purity igneous phosphate is becoming increasingly critical as recognized by the G7 Alliance
Discover how strategic partnerships, government support and a vertically integrated business model are positioning First Phosphate to meet this rapidly growing demand